We are live on ! Find out more
WA

Whitebox Advisors Portfolio holdings

AUM $7.65B
1-Year Est. Return 13.87%
This Fund
S&P 500
This Quarter Est. Return
+1.93%
1 Year Est. Return
+13.87%
3 Year Est. Return
+24.22%
5 Year Est. Return
+33.25%
10 Year Est. Return
+180.55%
AUM
$7.65B
AUM Growth
-$592M
Cap. Flow
-$3.5B
Cap. Flow %
-45.77%
Top 10 Hldgs %
31.69%
Holding
745
New
163
Increased
24
Reduced
37
Closed
79

Sector Composition

Rank Sector Weight
1 Miscellaneous 76.5%
2 Financials 9.04%
3 Healthcare 5.77%
4 Industrials 2.04%
5 Energy 1.79%

No holdings matched the selected filter criteria.

Similar funds

Whitebox Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Whitebox Advisors held 745 positions worth $7.65B, down 7.2% from $8.24B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Whitebox Advisors withdrew a net $3.5B in Q2 2026, closing 79 positions and reducing 37 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $52.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 81% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Whitebox Advisors opened a new position in Bio-Techne worth $148M.

  • Whitebox Advisors's largest Q2 2026 buy was Bio-Techne: 2,100,001 shares worth $148M.
  • Whitebox Advisors added most to Caesars Entertainment in Q2 2026, an estimated $92.1M increase.
  • Whitebox Advisors's biggest Q2 2026 reduction was Chart Industries, cutting an estimated $137M.
  • Whitebox Advisors fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $52.7M.
  • Whitebox Advisors's ten largest holdings make up 32% of its $7.65B portfolio in Q2 2026.
  • Whitebox Advisors opened 163 new positions and closed 79 in Q2 2026.
  • Whitebox Advisors's portfolio value fell 7.2% quarter-over-quarter to $7.65B.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.